Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Open-market sale President & CEO sold 14,100 shares at $10.90 ($153,690)
  2. 4 Open-market sale Chief R&D Officer sold 3,125 shares at $10.89 ($34,031)
  3. 4 Open-market sale Chief Financial Officer sold 5,700 shares at $10.90 ($62,130)
  4. 4 Open-market sale Chief Commercial Officer sold 6,100 shares at $10.90 ($66,490)
  5. 4 Open-market sale Exec. Director, Finance - PAO sold 445 shares at $10.90 ($4,851)
  6. 4 Open-market sale Chief Legal Officer sold 4,175 shares at $10.88 ($45,424)
  7. 8-K Event Regulation FD disclosure · Other events
  8. 4 Open-market sale Exec. Director, Finance - PAO sold 8,600 shares at $13.01 ($111,886)
  9. 4 Open-market sale President & CEO sold 297,573 shares at an average $12.94 ($3,851,918)
  10. 4 Grant or award Director acquired 421 shares (grant or award)
  11. 4 Grant or award Director acquired 421 shares (grant or award)
  12. 4 Grant or award Director acquired 842 shares (grant or award)
  13. 4 Grant or award Director acquired 1,497 shares (grant or award)
  14. 4 Open-market sale Chief Discovery Officer sold 31,515 shares at $13.88 ($437,428)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 8-K Event Executive or director change · Regulation FD disclosure
  18. 4 Grant or award Director acquired 404 shares (grant or award)
  19. 4 Grant or award Director acquired 809 shares (grant or award)
  20. 4 Grant or award Director acquired 1,438 shares (grant or award)

Page 16 of 99 · 1,967 filings